Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Merck & Co Incã®çŸåšã®åžå ŽäŸ¡æ Œã¯ï¿¥22,496.31ã24æéã®ååŒé«ã¯ï¿¥155.56Mã§ãããã®è³ç£ã®æäŸ¡ç·é¡ã¯ãéå»24æéã§1.09%å€åããï¿¥55.5Tãšãªã£ãŠããŸãã
ããŒã¯ã³åãããMerck & Co Incã¯ï¿¥22,640.56ã§ååŒãããŠãããããŒã¯ã³åãããæäŸ¡ç·é¡ã¯ï¿¥47.86Mã24æéã®ååŒé«ã¯ï¿¥108.38Mã§ãããã®ããŒã¯ã³åãããè³ç£ã¯ãéå»24æéã§-0.30%å€åããŸããã